[Retracted] Using Haemocoagulase Agkistrodon in Patients Undergoing Transurethral Plasmakinetic Resection of the Prostate: A Pilot, Real-World, and Propensity Score-Matched Study

Table 4

Baseline characteristics of patients given haemocoagulase agkistrodon for injection or ethylenediamine diaceturate injection before and after propensity score matching.

Baseline	Before propensity score matching			After propensity score matching
	Haemocoagulase agkistrodon ()	Ethylenediamine Diaceturate ()		Haemocoagulase agkistrodon ()	Ethylenediamine Diaceturate ()
Age (years)			0.25			0.96
Body mass index (kg/m^2)			0.11			0.19
Prostate volume (mL)	51.65 (33.89, 81.68)	48.35 (39.77, 73.58)	0.73	57.29 (34.80, 74.40)	46.31 (39.30, 73.89)	0.65
Systolic pressure (mmHg)	132.00 (121.00, 142.00)	126.00 (116.00, 130.00)	0.04	133.00 (125.00, 140.00)	130.00 (116.00, 135.00)	0.08
Diastolic pressure (mmHg)	79.00 (70.00, 85.00)	80.00 (72.00, 86.00)	0.18			0.18
Fasting blood glucose (ng/mL)	5.12 (4.82, 5.60)	4.97 (4.69, 5.40)	0.17	5.06 (4.75, 5.50)	4.86 (4.40, 5.32)	0.22
Hypertension status ( [%])			1			1
Yes	13 (11.50%)	4 (10.81%)		3 (10.34%)	4 (13.79%)
No	100 (88.50%)	33 (89.19%)		26 (89.66%)	25 (86.21%)
History of smoking ( [%])			<0.001			1
Yes	29 (25.66%)	21 (56.76%)		16 (55.17%)	16 (55.17%)
No	84 (74.34%)	16 (43.24%)		13 (44.83%)	13 (44.83%)
History of drinking ( [%])			0.71			0.77
Yes	30 (26.55%)	11 (29.73%)		9 (31.03%)	8 (27.59%)
No	83 (73.45%)	26 (70.27%)		20 (68.97%)	21 (72.41%)